Treasure Island stirs up 6 billion injections that will be the third to be reviewed.

Pharmaceutical Network July 13th, July 10, CDE official website shows that Treasure Island Pharmaceuticals hydrochloric acid ammonia broso injection 4 class imitation listing application was accepted-meter net data show that in 2019 China's public medical institutions terminal sales of ammonia bromine injections nearly 6 billion yuan, while hydrochloric acid ammonia brocoma injections only Sichuan Delta Kanghuakang Pharmaceuticals and China Central Pharmaceuticals have been ratedthe sales of ammonia bromine injections in China's public medical institutions in recent years (units: 10,000 yuan) data show that in 2019 in China's urban public hospitals, county-level public hospitals, urban community centers and township hospitals (referred to as China's public medical institutions) terminal sales of amambrominol injections nearly 6 billion yuan's main manufacturers are Bollinger Ingham, Tianjin Pharmaceutical Research Institute Pharmaceuticals, Shandong Luoxin Pharmaceuticals, Guorui Pharmaceuticals, among them, Bollinger Ingham has the largest market share, up to 21.74 percentconsistency evaluation, hydrochloric acid ammonia bromine injection seisizer only Sichuan Delta Kanghuakang Pharmaceutical sands and Huazhong Pharmaceutical Industry have been evaluated, both are certified by imitation 4 categories, as the same through consistency evaluationBefore, hydrochloric acid ammonia bromine injection to copy the 4 categories of declaration of Yangzijiang Pharmaceuticals, Beijing Four Rings Pharmaceuticals and other 8 enterprisesand consistency evaluation submitted supplementary applications are Tianjin Pharmaceutical Research Institute Pharmaceuticals, Guoguo Rui Pharmaceutical, Stone Pharmaceutical Group, Europe-Italian Pharmaceuticals and other 18 enterprisessource: CDE official website, the net database of the meter, if there is a leak, please point to the positive.